Efficacy and safety of Runzao Zhiyang capsule for chronic urticaria: a systematic review and meta-analysis of randomized controlled trials

Background: Chronic urticaria (CU) is a commonly seen skin disorder featured by recurring wheals, with or without angioedema, lasting for at least 6 weeks. Runzao Zhiyang capsule (RZC) has been widely applied to treat patients with CU. This study is aimed at systematically evaluating the efficacy an...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jian-Feng, Wang, Ying-Dong, Lin, Peng, Li, Jun-Chen, Guo, Chen-Qi, Zhai, Jing-Bo, Zhang, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10491456/
https://www.ncbi.nlm.nih.gov/pubmed/37693898
http://dx.doi.org/10.3389/fphar.2023.1200252

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10491456/
https://www.ncbi.nlm.nih.gov/pubmed/37693898
http://dx.doi.org/10.3389/fphar.2023.1200252

Ejemplares similares